Affiliation:
1. Saratov State Medical University
Abstract
Objective: to explore clinical characteristics and the influence of anemic syndrome on long-term outcomes of patients with coronary artery disease underwent percutaneous coronary intervention (PCI). Review writing methodology. A systematic review was performed according to PRISMA methodology using PubMed, Google Scholar, eLibrary, CyberLeninka databases. Search depth —from 2000 to 2022. The review included 16 original studies. Conclusion. It was shown that the patients with PCI and anemia were older, predominantly male sex as compared with patients without anemic syndrome. The risk of adverse short- and long-term outcomes (myocardial infarction, stroke, major bleeding, cardiovascular and non-cardiovascular death) was significantly increased in anemic patients even with a slight decrease in hemoglobin according to WHO criteria (less than 130 g/lfor men and less than 120 g/l for women). But majority of patients were not fit with the criteria of light grade of anemia according federal clinical guidelines (hemoglobin 90-110 g/l). The influence of anemia on outcomes becomes the most significant 12 months after PCI.
Publisher
LLC Science and Innovations
Reference36 articles.
1. Alekyan BG, Boytsov SA, Ganyukov VI, Manoshkina EM. Impact of the COVID-19 pandemic on myocardial revasculariza-tion in patients with acute coronary syndrome in the Russian Federation. Rational Pharmacotherapy in Cardiology. 2022; 18 (4): 411-9 DOI:10.20996/1819-6446 -2022-08-03
2. Erlikh AD. How "real life" treatment of patients with ST-elevation acute coronary syndrome has changed during recent several years (data from a series of the Russian RECORD Registries). Cardiology. 2018; 58 (7): 23-31. DOI:0.18087/cardio.2018.7.10140
3. Alekyan BG, Karapetyan NG, Meleshenko NN, Revish-vili ASh. Results of myocardial revascularization in patients with coronary artery disease with intermediate coronary stenosis under control of instantaneous wave-free ratio. Russian Journal of Endovascular Surgery. 2021; 8 (1): 20-6. DOI:10.24183/2 409-4080-2021 -8-1 -20-26
4. Ziankou АА, Isaev MN, Kondratyev DA, et al. Minimally invasive multivessel coronary artery bypass grafting safe and efficient: The experience of the first 500 cases. Clinical and Experimental Surgery. Petrovsky Journal. 2021; 9 (4): 20-8. DOI:10.33029/2308-1198-2021-9-4-20-28
5. Vasiliev DK, Rudenko BA, Shanoyan AS, et al. Endovas-cular myocardial revascularization in patients with multivessel coronary artery disease with chronic total occlusion and high surgical risk. Cardiovascular Therapy and Prevention. 2020; 19 (6): 2697. DOI:10.15829/1728-8 800-2020-2697